299 related articles for article (PubMed ID: 18079050)
1. Screening for prostate cancer in 2007: the PSA era and its challenges are not over.
Shariat SF; Karakiewicz PI
Eur Urol; 2008 Mar; 53(3):457-60. PubMed ID: 18079050
[No Abstract] [Full Text] [Related]
2. PSA and prostate cancer screening: the challenge of the new millennium.
Bjartell A
Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305
[No Abstract] [Full Text] [Related]
3. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
[TBL] [Abstract][Full Text] [Related]
4. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Rosser CJ; Parker A
J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
[No Abstract] [Full Text] [Related]
5. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
[No Abstract] [Full Text] [Related]
6. Prostate cancer: is the PSA test the answer?
Berlin B
N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148
[No Abstract] [Full Text] [Related]
7. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
8. [Elevated PSA--what to do?].
Machemer H; Rohde D
MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
[No Abstract] [Full Text] [Related]
9. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
[TBL] [Abstract][Full Text] [Related]
10. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
Sarrats A; Comet J; Tabarés G; Ramírez M; Aleixandre RN; de Llorens R; Peracaula R
Prostate; 2010 Jan; 70(1):1-9. PubMed ID: 19670261
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
Höltl W; Lunglmayr G
Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
[No Abstract] [Full Text] [Related]
12. [Screening for prostate cancer: role of PSA in 2006].
Roumeguère T; Peltier A
Rev Med Brux; 2006 Sep; 27(4):S225-31. PubMed ID: 17091883
[TBL] [Abstract][Full Text] [Related]
13. PSA: prostate-specific antigen, persisting scientific ambiguities.
Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
[No Abstract] [Full Text] [Related]
14. Prostate specific antigen testing for the diagnosis of prostate cancer.
McKenzie P; Delahunt B; deVoss K; Ross B; Tran H; Sikaris K
Pathology; 2011 Aug; 43(5):403. PubMed ID: 21753713
[No Abstract] [Full Text] [Related]
15. [The density of prostate specific antigen of the transition zone as an early predictor of prostate cancer].
Topuzov ME; Prialukhin AE; Zhivov AV; Plekhanov AIu
Vestn Khir Im I I Grek; 2008; 167(6):119-21. PubMed ID: 19241832
[TBL] [Abstract][Full Text] [Related]
16. [Prostatic cancer--can unnecessary therapy be avoided? Prostate-specific antigens (PSA) kinetics can guide the management].
Malmström PU
Lakartidningen; 2006 Feb 1-7; 103(5):279. PubMed ID: 16512565
[No Abstract] [Full Text] [Related]
17. An overview of PSA/free PSA with special reference to recent trends in diagnosis of prostatic cancer.
Goyal SR; Talib VH; Khurana SK
Indian J Pathol Microbiol; 1999 Apr; 42(2):171-8. PubMed ID: 10639780
[No Abstract] [Full Text] [Related]
18. Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen.
Cheng CW; Chan LW; Ng CF; Chan CK; Tse MK; Lai MM
Int J Urol; 2006 Apr; 13(4):463-5. PubMed ID: 16734876
[TBL] [Abstract][Full Text] [Related]
19. PSA screening: the bottom line.
Elhilali MM
CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
[No Abstract] [Full Text] [Related]
20. [Prostate specific antigen: utilization modalities and interpretation].
Hannoun-Levi JM; Ginot A; Thariat J
Cancer Radiother; 2008 Dec; 12(8):848-55. PubMed ID: 18539498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
